General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Cash Flows

v3.20.4
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities        
Net loss $ (4,750,691) $ (2,326,332) $ (16,384,104) $ (12,403,215)
Adjustment to reconcile net loss to net cash used in operating activities        
Bad debt expense 12,450 252,809 1,094,507 345,941
Stock-based compensation expense 681,419 161,165 1,166,130 3,884,111
Depreciation and amortization 1,171,022 17,899 1,315,898
Foreign currency loss 4,901    
Equity in losses of investee 1,534 3,692
Debt issuance costs classified as financing     1,177,390
Change in fair value of convertible notes (778,000) (766,000)
Change in fair value of contingent consideration (389,000) (998,000)
Changes in operating assets and liabilities:        
Accounts receivable (9,298) (1,508,217) (1,621,262) (1,572,889)
Prepaid expenses and other current assets (74,023) (292,272) (592,807) (351,144)
Other assets     (58,925)
Accounts payable and accrued liabilities (296,802) 274,566 1,602,751 893,845
Deferred revenue 245,329 278,208 (286,922) 154,756
Net cash used in operating activities (4,181,159) (3,142,174) (14,347,652) (9,048,595)
Cash flows from investing activities        
Developed software additions (624,863) (519,739) (3,102,728)
Furniture, fixtures, and equipment additions (12,203) (156,636)
Cash paid for business combinations, net of cash acquired (5,067,740) (88,720)
Investment in equity method investee (250,000)
Cash received in connection with the reverse merger 18,843,483
Net cash provided by investing activities (5,704,806) (519,739) (3,598,084) 18,843,483
Cash flows from financing activities        
Cash paid for deferred stock offering costs (12,668)
Proceeds from the issuance of long term debt 17,164,600
Cash paid for debt issuance costs (1,177,390)
Proceeds from the exercise of warrants 4,242,454 4,247,065
Proceeds from the issuance of common stock 10,000,000
Net cash provided by financing activities (12,668) 4,242,454 20,234,275 10,000,000
Net increase in cash and restricted cash (9,897,970) 580,541 2,288,539 19,794,888
Cash and restricted cash - beginning of period 24,655,828 22,367,289 22,367,289 2,572,401
Cash and restricted cash - end of period 14,757,858 22,947,830 24,655,828 22,367,289
Cash paid for taxes    
Cash paid for interest 1,974
Supplemental disclosure of non-cash investing and financing activity:        
Cashless exercise of options     19
Capitalized software included in accrued expense 807,218    
Acquisition of noncontrolling interest 4,695,437    
Special voting preferred stock issued in business combination 25,203,490    
Conversion of exchangeable shares to common stock $ 4,798,271    
Stock-based compensation capitalized as software development     87,104
Assets acquired and liabilities assumed in business combinations and reverse merger:        
Accounts receivable     77,505
Prepaid expenses and other current assets     27,860 35,292
Fixed assets     2,410
Intangible assets     8,010,000
Goodwill     20,254,309
Accounts payable and accrued liabilities     1,441,062
Deferred revenue     31,220
Contingent consideration     $ 1,387,000